BVF »

Crescent Biopharma shares owned by BVF

Quarter-by-quarter ownership of Crescent Biopharma (CBIO) shares owned by BVF from 13F filings

Historical chart of BVF investment in Crescent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Crescent Biopharma held by BVF consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crescent Biopharma by BVF

Quarter filed Position value Share count Share price at filing
2025-09-30 $17M 1.4M 11.89
2025-06-30 $22M 1.4M 16.14

More positions owned by BVF

Kymera Therapeutics (KYMR)
Revolution Medicines (RVMD)
Protagonist Therapeutics (PTGX)
Moonlake Immunotherapeutics Class A Ord (MLTX)
Cidara Therapeutics Com New (CDTX)
Gh Research Ordinary Shares (GHRS)
Mirum Pharmaceuticals (MIRM)
Xoma Royalty Corporation Com New (XOMA)
Structure Therapeutics Sponsored Ads (GPCR)
Kura Oncology (KURA)
Septerna (SEPN)
Palvella Therapeutics Inc Ne (PVLA)
Nektar Therapeutics Com New (NKTR)
Zymeworks Del (ZYME)
Axsome Therapeutics (AXSM)

View all positions for BVF

Top funds holding Crescent Biopharma

FMR
Fairmount Funds Management
VR Adviser
BVF
Tang Capital Management
Vanguard Group
Logos Global Management
Deep Track Capital
Boxer Capital Management
Perceptive Advisors
Commodore Capital
Driehaus Capital Management
Frazier Life Sciences Management
Adage Capital Partners GP
Soleus Capital Management

View all funds holding Crescent Biopharma